Form 4: Avid Bioservices Chief Commercial Officer Matthew Kwietniak Reports Disposal of Shares and Derivative Securities Following Merger
SEC Form 4 Filing
Matthew Kwietniak, Chief Commercial Officer of Avid Bioservices, reports the disposal of common stock, restricted stock units (RSUs), and performance stock units (PSUs) due to the merger with Space Mergerco, Inc., resulting in a cash payment of $12.50 per share.
Summary
- On February 5, 2025, Matthew R. Kwietniak, Chief Commercial Officer of Avid Bioservices, Inc. (CDMO), filed a Form 4.
- The filing reports the disposal of common stock, restricted stock units (RSUs), and performance stock units (PSUs) due to the merger of Space Mergerco, Inc. with Avid Bioservices, Inc.
- Each outstanding share of common stock was converted into the right to receive a cash payment of $12.50 per share.
- Vested and unvested RSUs were cancelled and converted into the right to receive a cash payment of $12.50 per share.
- Vested and unvested PSUs were cancelled and converted into the right to receive a cash payment of $12.50 per share, based on target or actual performance.
- The merger agreement, dated November 6, 2024, outlines the terms and conditions of the merger.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive as it reflects the completion of a merger, which typically provides shareholders with a defined cash payment. The document is a standard regulatory filing related to the merger.
Future Outlook
The document does not contain any specific forward-looking statements beyond the completion of the merger.
Industry Context
This announcement reflects a merger and acquisition (M&A) activity within the bioservices industry, where companies are often acquired to consolidate market share, gain access to new technologies, or achieve synergies.
Stakeholder Impact
- Shareholders received $12.50 per share as a result of the merger.
- Employees' stock-based compensation (RSUs and PSUs) was converted to cash payments.
Key Dates
| Date | Description |
|---|---|
| November 6, 2024 | Date of the Merger Agreement between Avid Bioservices, Space Finco, Inc., and Merger Sub. |
| February 5, 2025 | Date of transaction (disposal of securities) and earliest transaction date reported on Form 4. |
| February 7, 2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, Avid Bioservices, Merger, Matthew Kwietniak, CDMO, Space Mergerco, RSU, PSU, Beneficial Ownership, Disposal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.